Compare Novartis with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs TRIMURTHI DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS TRIMURTHI DRUGS NOVARTIS/
TRIMURTHI DRUGS
 
P/E (TTM) x 83.6 -1.6 - View Chart
P/BV x 2.6 0.5 513.8% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 NOVARTIS   TRIMURTHI DRUGS
EQUITY SHARE DATA
    NOVARTIS
Mar-21
TRIMURTHI DRUGS
Mar-20
NOVARTIS/
TRIMURTHI DRUGS
5-Yr Chart
Click to enlarge
High Rs7707 11,000.0%   
Low Rs5012 27,081.1%   
Sales per share (Unadj.) Rs154.512.6 1,221.3%  
Earnings per share (Unadj.) Rs8.5-0.3 -2,647.3%  
Cash flow per share (Unadj.) Rs13.4-0.1 -15,949.9%  
Dividends per share (Unadj.) Rs10.000-  
Avg Dividend yield %1.60-  
Book value per share (Unadj.) Rs289.213.1 2,209.6%  
Shares outstanding (eoy) m24.698.10 304.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x4.10.3 1,176.0%   
Avg P/E ratio x75.1-13.8 -542.5%  
P/CF ratio (eoy) x47.5-52.9 -89.7%  
Price / Book Value ratio x2.20.3 650.0%  
Dividend payout %118.10-   
Avg Mkt Cap Rs m15,69136 43,777.6%   
No. of employees `000NANA-   
Total wages/salary Rs m1,0857 15,840.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3,814102 3,722.7%  
Other income Rs m3326 5,524.1%   
Total revenues Rs m4,146108 3,822.5%   
Gross profit Rs m267-5 -5,368.2%  
Depreciation Rs m1222 6,366.5%   
Interest Rs m771 6,000.0%   
Profit before tax Rs m400-2 -18,623.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1910 43,500.0%   
Profit after tax Rs m209-3 -8,069.5%  
Gross profit margin %7.0-4.9 -144.2%  
Effective tax rate %47.8-20.5 -232.9%   
Net profit margin %5.5-2.5 -216.7%  
BALANCE SHEET DATA
Current assets Rs m9,224114 8,096.5%   
Current liabilities Rs m3,57318 19,760.0%   
Net working cap to sales %148.293.6 158.4%  
Current ratio x2.66.3 41.0%  
Inventory Days Days17618 995.7%  
Debtors Days Days37125 29.6%  
Net fixed assets Rs m2,48023 10,647.5%   
Share capital Rs m12381 152.3%   
"Free" reserves Rs m7,01825 28,038.4%   
Net worth Rs m7,141106 6,735.3%   
Long term debt Rs m08 0.0%   
Total assets Rs m11,703137 8,528.9%  
Interest coverage x6.2-0.7 -914.2%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.30.7 43.6%   
Return on assets %2.4-1.0 -254.7%  
Return on equity %2.9-2.4 -119.8%  
Return on capital %6.7-0.8 -869.0%  
Exports to sales %9.30-   
Imports to sales %00-   
Exports (fob) Rs m354NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3540-   
Fx outflow Rs m9740-   
Net fx Rs m-6210-   
CASH FLOW
From Operations Rs m-6926 -11,020.7%  
From Investments Rs m9525 20,960.4%  
From Financial Activity Rs m-368-2 22,439.0%  
Net Cashflow Rs m-1099 -1,180.6%  

Share Holding

Indian Promoters % 0.0 66.9 -  
Foreign collaborators % 70.7 0.0 -  
Indian inst/Mut Fund % 0.8 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 29.3 33.1 88.6%  
Shareholders   45,141 2,391 1,888.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   A-1 ACID  TRIJAL IND.  RAMA VISION  ASIA PACK  TIRUPATI TYRES  



Today's Market

Sensex Recoups Early Losses as Energy, Metal Stocks Rally; Reliance & Tata Steel Top Gainers(10:30 am)

Asian share markets are trading lower today as the spread of the Omicron variant in developed nations threatened to derail economic recoveries and the tightening plans of some central banks.

Related Views on News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

Don't Sell these Stocks if the Market Falls(Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

How to Find Your Next 10-Bagger in this Market(Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Nov 29, 2021 03:13 PM

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS 8-QTR ANALYSIS

COMPARE NOVARTIS WITH

MARKET STATS